Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease: a prospective, large cohort study

BACKGROUND: Elevated lipoprotein(a) [Lp(a)] and fibrinogen (Fib) are both associated with coronary artery disease (CAD). The atherogenicity of Lp(a) can be partly due to the potentially antifibrinolytic categories. We hypothesize that patients with higher Lp(a) and Fib may have worse outcomes. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yan, Jin, Jing-Lu, Cao, Ye-Xuan, Liu, Hui-Hui, Zhang, Hui-Wen, Guo, Yuan-Lin, Wu, Na-Qiong, Gao, Ying, Hua, Qi, Li, Yan-Fang, Xu, Rui-Xia, Cui, Chuan-Jue, Liu, Geng, Dong, Qian, Sun, Jing, Li, Jian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528376/
https://www.ncbi.nlm.nih.gov/pubmed/33004038
http://dx.doi.org/10.1186/s12967-020-02546-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528376/
https://www.ncbi.nlm.nih.gov/pubmed/33004038
http://dx.doi.org/10.1186/s12967-020-02546-y

Ejemplares similares